英文名称:NCI-H929
货号:GCL-0509
价格: ¥2000.00 ¥2000.00
产品详情
产品信息
物种 | Human |
生长特性 | 悬浮细胞 |
细胞形态 | 淋巴母细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[GPM150110]+0.05 mM β-mercaptoethanol+10% FBS[163210]+1% P/S[GPB180120] 培养条件: 温度:37℃ |
推荐传代比例 | 5×10⁵-1×10⁶ cells/mL |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
年龄(性别) | 62Y |
组织来源 | 骨髓 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 骨髓瘤细胞 |
生物安全等级 | BSL-1 |
保藏机构 | ATCC; CRL-9068 DSMZ; ACC-163 ECACC; 9505041 |
相关文献
-
期刊:Expert Review of Hematology
DOI:10.1080/17474086.2025.2492881
影响因子:2.3
相关产品: Normal plasma Cells, U266 [U266B1] Cells Line, RPMI 8226 Cells Line, NCI-H929 Cells Line
-
Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib(2024)
期刊:Biochemistry and Biophysics Reports
DOI:10.1016/j.bbrep.2024.101781
影响因子:2.3
相关产品: NCI-H929 Cells Line
-
LAMP5 may promote MM progression by activating p38(2023)
期刊:PATHOLOGY & ONCOLOGY RESEARCH
影响因子:2.800
相关产品: RPMI 8226 Cells Line, U266 [U266B1] Cells Line, NCI-H929 Cells Line, AMO-1 Cells Line
-
期刊:MOLECULAR BIOTECHNOLOGY
DOI:10.1007/s12033-022-00618-6
影响因子:2.900
相关产品: NCI-H929 Cells Line, RPMI 8226 Cells Line, U266 [U266B1] Cells Line, Normal Plasma Cells, RPMI-1640, Fetal Bovine Serum
-
CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T?cells(2021)
期刊:Molecular Therapy-Oncolytics
DOI:10.1016/j.omto.2021.07.003
影响因子:5.700
相关产品: A549/DDP Cells Line, COS-1 Cells Line, K-562 [K562] Cells Line, NCI-H929 Cells Line
-
期刊:Acta Biochimica Et Biophysica Sinica
影响因子:3.500
-
期刊:Journal of Orthopaedic Surgery and Research
DOI:10.1186/s13018-021-02819-2
影响因子:2.600
相关产品: RPMI 8226 Cells Line, NCI-H929 Cells Line, U266 [U266B1] Cells Line, RPMI-1640